Details for Patent: 7,858,662
✉ Email this page to a colleague
Which drugs does patent 7,858,662 protect, and when does it expire?
Patent 7,858,662 protects VEREGEN and is included in one NDA.
This patent has thirty-one patent family members in twenty countries.
Summary for Patent: 7,858,662
| Title: | Medicament for the treatment of viral skin and tumour diseases |
| Abstract: | The invention relates to a medicament containing a compound of general formula (1), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkynyl group, preferably a C11-C15 alkyl, alkylene or alkynyl group, particularly a C11-C13 alkyl, alkylene or alkynyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkynyl group, preferably a C1-C6 alkyl, alkylene or alkynyl group, in particular a C2-C4 alkyl, alkylene or alkynyl group, most preferably a C3 alkyl group, a —[CH2—(CH2)m—O]nH group with n=1 to 10, preferably n=1 to 5, m=1 to 5, preferably m=1 to 3, a —CH2—[CH—(OH)]p[CH2—(R3)]— group, where R3=independent H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tumor diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses and a topically acting medicament formulation and the use thereof. |
| Inventor(s): | Yunik Chang, Robert Lathrop, Erwin Böhm, Irene Gander-Meisterernst, Regina Greger, Johanna Holldack, Ulrich Moebius |
| Assignee: | ANI Pharmaceuticals Inc |
| Application Number: | US10/495,889 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 7,858,662
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | VEREGEN | sinecatechins | OINTMENT;TOPICAL | 021902-001 | Oct 31, 2006 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | TREATMENT OF GENITAL WARTS | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,858,662
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 101 56 794 | Nov 19, 2001 |
| PCT Information | |||
| PCT Filed | November 18, 2002 | PCT Application Number: | PCT/EP02/12919 |
| PCT Publication Date: | May 30, 2003 | PCT Publication Number: | WO03/043628 |
International Family Members for US Patent 7,858,662
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1448186 | ⤷ Start Trial | 300550 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1448186 | ⤷ Start Trial | C01448186/01 | Switzerland | ⤷ Start Trial |
| European Patent Office | 1448186 | ⤷ Start Trial | 140 5025-2012 | Slovakia | ⤷ Start Trial |
| European Patent Office | 1448186 | ⤷ Start Trial | C300550 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1448186 | ⤷ Start Trial | CA 2012 00040 | Denmark | ⤷ Start Trial |
| European Patent Office | 1448186 | ⤷ Start Trial | 12C0058 | France | ⤷ Start Trial |
| European Patent Office | 1448186 | ⤷ Start Trial | CR 2012 00040 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
